![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
The item has been added to your shopping cart.
Home » FDA Clears TrapLiner Catheter for Marketing
FDA Clears TrapLiner Catheter for Marketing
February 23, 2017
Teleflex has received FDA marketing clearance for the TrapLiner catheter.
The device is intended for use with guide catheters to access the coronary and/or peripheral vasculature. It features of an integrated balloon for trapping a standard 0.014inch guide-wire within a guide catheter.
The device was developed by Vascular Solutions, which was acquired by Teleflex on Feb. 17, 2017. — Cynthia Jessup
Upcoming Events
-
21Oct